Inhibition of store-operated Ca2+ entry channels and K+ channels by caffeic acid phenethylester in T lymphocytes.
The increase of cytoplasmic Ca2+ concentration (Delta[Ca2+]c) in response to antigenic stimulation is a critical step of signals activating immune responses. In addition, the voltage-gated K+ channels (Kv) in T lymphocytes draw attention as an effective target of immune-modulation. Caffeic acid phenethyl ester (CAPE), an active component of propolis, shows strong anti-inflammatory effects and T cell suppression. Although various mechanisms have been suggested for the action of CAPE, the effects of CAPE on intracellular Ca2+ signaling and ion channels are unknown. Here we investigated the effects of CAPE on Delta[Ca2+](c), Ca2+-release activated Ca2+ current (I(CRAC)), and Kv current (I(Kv)) in Jurkat T cells, and on Ca2+-activated K+ channel current (I(SK4)) overexpressed in HEK-293 cells. I(CRAC) was induced by dialyzing T cells and Orai1/STIM1 overexpressing HEK293 cells with InsP(3)/BAPTA-containing pipette solution. CAPE concentration-dependently decreased both T cell receptor (CD3)- and thapsigargin-induced Delta[Ca2+](c). The phosphorylation of PLCgamma(1) by CD3 stimulation was not affected by CAPE. I(CRAC) was almost completely blocked by 25 microM CAPE. CAPE also inhibited the I(Kv) and I(SK4). Albeit the strong inhibition of Ca2+ influx via CRAC, the suppression of IL-2 secretion by CAPE was similarly observed in human peripheral T cells when the CRAC pathway was circumvented by ionomycin. Although the unspecific inhibition of ion channels by CAPE suggested an intriguing mechanism, the effects of CAPE on signaling pathways other than I(CRAC) seem to play dominant roles in the immunomodulation by CAPE.
Nam
Joo Hyun
JH
Department of Physiology, Seoul National University College of Medicine, Republic of Korea.
Shin
Dong Hoon
DH
Zheng
Haifeng
H
Kang
Jae Seung
JS
Kim
Woo Kyung
WK
Kim
Sung Joon
SJ
D018106:CD28 Antigens / Q000378:metabolism; D017252:CD3 Complex / Q000378:metabolism; D002109:Caffeic Acids / Q000494:pharmacology*; D002118:Calcium / Q000037:antagonists & inhibitors*; D020013:Calcium Signaling / Q000187:drug effects; D002460:Cell Line; D002614:Chelating Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004533:Egtazic Acid / Q000494:pharmacology; D004594:Electrophysiology; D006801:Humans; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism; D007376:Interleukin-2 / Q000037:antagonists & inhibitors; D015759:Ionomycin / Q000494:pharmacology; D019169:Jurkat Cells; D007668:Kidney / Q000166:cytology; D018408:Patch-Clamp Techniques; D010626:Phenylethyl Alcohol / Q000031:analogs & derivatives* / Q000494:pharmacology; D010835:Phytohemagglutinins / Q000494:pharmacology; D024642:Potassium Channels, Voltage-Gated / Q000037:antagonists & inhibitors*; D013601:T-Lymphocytes / Q000378:metabolism*; D019284:Thapsigargin / Q000494:pharmacology; D013997:Time Factors
D018106:CD28 Antigens; D017252:CD3 Complex; D002109:Caffeic Acids; D002614:Chelating Agents; D007376:Interleukin-2; D010835:Phytohemagglutinins; D024642:Potassium Channels, Voltage-Gated; D004533:Egtazic Acid; D015759:Ionomycin; D019284:Thapsigargin; D015544:Inositol 1,4,5-Trisphosphate; C055494:caffeic acid phenethyl ester; D010626:Phenylethyl Alcohol; D002118:Calcium